2-Methoxypropene | CAS:116-11-0

We serve 2-Methoxypropene CAS:116-11-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Methoxypropene

Chemical Name:2-Methoxypropene
CAS.NO:116-11-0
Synonyms:2-Methoxypropene
Isopropenyl Methyl Ether
2-methoxyprop-1-ene
2-Methoxy-1-propene
 
Physical and Chemical Properties:
Density 0.8±0.1 g/cm3
Boiling Point 32.0±9.0 °C at 760 mmHg
Melting Point < 25ºC
Molecular Formula C4H8O
Molecular Weight 72.106
Flash Point -29.4±0.0 °C
Vapour Pressure 590.8±0.1 mmHg at 25°C
Index of Refraction 1.374
 
Specification:
Appearance:Colorless transpatent liquid
Assay:≥99.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Orlistat(CAS:96829-58-2).



Contact us for information like 2-Methoxypropene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Methoxy-1-propene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methoxy-1-propene Use and application,2-Methoxy-1-propene technical grade,usp/ep/jp grade.


Related News: AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.dAMP manufacturer Social media users — including numerous medical experts — questioned whether the findings were supported by clinical evidence from treating coronavirus patients.Benzotriazol-1-yloxytris(dimethylamino)phosphonium Hexafluorophosphate supplier Social media users — including numerous medical experts — questioned whether the findings were supported by clinical evidence from treating coronavirus patients.1-(2-Chlorophenyl)-3-methyl-2-pyrazolin-5-one vendor Social media users — including numerous medical experts — questioned whether the findings were supported by clinical evidence from treating coronavirus patients.Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.